Abiomed (ABMD) Tops Q4 EPS by 16c

May 3, 2018 7:06 AM EDT

Abiomed (NASDAQ: ABMD) reported Q4 EPS of $0.80, $0.16 better than the analyst estimate of $0.64. Revenue for the quarter came in at $174.4 million versus the consensus estimate of $164.31 million.

GUIDANCE:

Abiomed sees FY2019 revenue of $740-770 million, versus the consensus of $747.3 million.

For earnings history and earnings-related data on Abiomed (ABMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings